Anti-human PCSK9 monoclonal antibody, bococizumab biosimilar (PF-04950615, RN316)

Home/ Products / Biosimilar Antibodies

PRODUCT

  • SKU

    DMS1141-100ug

  • Size

    100 ug

  • Price

    $350

1
This monoclonal antibody is part of a collection of biosimilar antibodies in reference to those approved or in clinical investigation. The biosimilars are for Research Use Only and should not be used in therapeutic or diagnostic procedures in humans or animals.
target PCSK9
alias FH3, FHCL3, HCHOLA3, LDLCQ1, NARC-1, NARC1, PC9
gene id Uniprote ID: Q8NBP7
host species Humanized
reactivity Human
iso type IgG2
formulation Lyophilized from sterile PBS, pH 7.4. Typically, 5% - 8% trehalose is added as a protective agent prior to lyophilization.
reconstitution Reconstitute lyophilized powder with water to a concentration of 100 ug/ml, solubilize at RT for 30 minutes with occasional gentle tapping. It is recommended that 0.1% HSA be added as a carrier protein for long-term storage.
applications Flow Cytometry
dilution Flow Cyt 1:100
shipping Shipped at ambient conditions.
storage Lyophilized form is stable for 1 week at room temperature. Store at -20 °C to -80 °C for 12 months in lyophilized form. After reconstitution, store at 4 °C for 2-7 days or at below -20 °C for up to 3 months.
note Other commonly used names in publications refering to this antibody: PF-04950615, RN-316, RN316

Images

Flow cytometry analysis under cell membrane permeable condition with 1 ug/mL anti-PCSK9 (bococizumab biosimilar) mAb on Expi293 cells transfected with Human PCSK9 protein (Blue histogram) or Expi293 transfected with irrelevant protein (Red histogram).


PRODUCT

  • SKU

    DMS1141-100ug

  • Size

    100 ug

  • Price

    $350

1